![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Comparative Resistance Analysis Between Cirrhotic and Non-cirrhotic Treatment Experienced Patients Who Failed Treatment With a Combination of Vaniprevir (MK-7009) and Pegylated Interferon and Ribavirin (P/R)
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Steve Ludmerer, Richard Barnard, Stuart Black, Joann Brunhoffer, Anita Howe, Peggy May Tan Hwang, Rong Liu, Amy Zhou, and Niloufar Mobashery
Merck & Co., Inc., Whitehouse Station, NJ, USA
![EASL1.gif](../images/042114/042114-2/EASL1.gif)
![EASL2.gif](../images/042114/042114-2/EASL2.gif)
![EASL3.gif](../images/042114/042114-2/EASL3.gif)
![EASL4.gif](../images/042114/042114-2/EASL4.gif)
![EASL5.gif](../images/042114/042114-2/EASL5.gif)
![EASL6.gif](../images/042114/042114-2/EASL6.gif)
![EASL7.gif](../images/042114/042114-2/EASL7.gif)
![EASL8.gif](../images/042114/042114-2/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|